New search | Conferencedetail
Print view
 
 

Antigen-Specific Immune Tolerance Europe Summit

evvnt Platform / evvnt
Conference themes
The clinical heterogeneity of more than 80 autoimmune diseases presents a significant challenge with respect to the development of therapies designed to re-establish self-tolerance. As the first generation of antigen-specific immune tolerance therapies enters the clinic and excitement around the recent deals, partnerships, IPOs and investments reaching new heights, now is the time for an industry forum for large pharma, pioneering biotech and academia to unite.
Professional congress organizer (PCO)
Hanson Wade
Notes
Brochure: https://go.evvnt.com/264511-0?pid=4832

Speakers: Robert (Bob) Anderson (ImmusanT), Arpita Maiti (Pfizer), Keith Martin (Apitope), Tim Jessen (Topas Therapeutics), Lawrence Steinman (Tolerion), David Wraith (University of Birmingham)
 

Enquiries and Registration:

https://go.evvnt.com/264511-1?pid=4832
Mr. Hanson Wade
 
Categories
Health Services, Pharmacology and Toxicology
Languages
English
Congress fees
GBP 2.897,00
(Conference + 2 Workshops Earlybird (Book by 07/09/18): GBP 2297.0, Conference + 2 Workshops (standard rate): GBP 2897.0, Conference + 1 Workshop Earlybird (Book by 07/09/18): GBP 1898.0, Workshop: GBP 499.0)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Anästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthEuropean Health Forum GasteinHilfswerk AustriaCenter of ExcellenceCharité International AcademySwiss Tropical and Public Health InstituteOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation

Facebook

Give us your professional opinion

Start survey

Start survey